Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C McArthur

Showing results (331-340 of 359) with videos related to

Pageof 36
Sort By:
Neurobiology of Disease|May 16, 2006
Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenylJadwiga Turchan-Cholewo, Yiling Liu, Suzanne Gartner, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
Neurology|May 12, 2010
Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIVC L Cherry, J S Affandi, B J Brew, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous systemScott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.
Archives of Neurology|June 11, 2008
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisChitra Krishnan, Adam I Kaplin, Robert A Brodsky, et al.
Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.
Muscle & Nerve|July 23, 2016
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathyJennifer S Gewandter, Laurie Burke, Guido Cavaletti, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2018
Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fractureL M Giangregorio, J C Gibbs, J A Templeton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2012
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER CohortMaiko Sakamoto, Thomas D Marcotte, Anya Umlauf, et al.
Pageof 36

Showing results (331-340 of 359) with videos related to

Sort By:
Pageof 36
Neurobiology of Disease|May 16, 2006
Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenylJadwiga Turchan-Cholewo, Yiling Liu, Suzanne Gartner, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
Neurology|May 12, 2010
Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIVC L Cherry, J S Affandi, B J Brew, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous systemScott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.
Archives of Neurology|June 11, 2008
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisChitra Krishnan, Adam I Kaplin, Robert A Brodsky, et al.
Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.
Muscle & Nerve|July 23, 2016
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathyJennifer S Gewandter, Laurie Burke, Guido Cavaletti, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2018
Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fractureL M Giangregorio, J C Gibbs, J A Templeton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2012
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER CohortMaiko Sakamoto, Thomas D Marcotte, Anya Umlauf, et al.
Pageof 36